naltrexone has been researched along with 6alpha-iodo-3,14-dihydroxy-17-(cyclopropylmethyl)-4,5alpha-epoxymorphinan in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berman, KF; de Costa, BR; George, C; Iadarola, MJ; Jacobson, AE; Mahboubi, A; Newman, AH; Rice, KC; Rothman, RB | 1 |
1 other study(ies) available for naltrexone and 6alpha-iodo-3,14-dihydroxy-17-(cyclopropylmethyl)-4,5alpha-epoxymorphinan
| Article | Year |
|---|---|
Probes for narcotic receptor mediated phenomena. 18. Epimeric 6 alpha- and 6 beta-iodo-3,14-dihydroxy-17-(cyclopropylmethyl)-4,5 alpha-epoxymorphinans as potential ligands for opioid receptor single photon emission computed tomography: synthesis, evaluati
Topics: Animals; Binding Sites; Blood-Brain Barrier; Brain; Chromatography, High Pressure Liquid; Guinea Pigs; Indicators and Reagents; Iodine Radioisotopes; Male; Molecular Structure; Morphinans; Rats; Rats, Inbred Strains; Receptors, Opioid; Tomography, Emission-Computed, Single-Photon; X-Ray Diffraction | 1992 |